Use of Topical Subgingival Application of Simvastatin Gel in the Treatment of Peri-Implant Mucositis
Trial · NCT03400475
Outcomes18
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 18 of 18
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change in Interleukin 1 B at Base to 24 Hours | Baseline- 24hrs | Micrograms per deciliter (ug/dl) | MEAN | |
| PRIMARY | Change in Interleukin 1 B at Base to 1 Week | Baseline - 1 week | Micrograms per deciliter (ug/dl) | MEAN | |
| PRIMARY | Change in Interleukin 1 B 24 Hours - 1 Week | 24 hours - 1 week | Micrograms per deciliter (ug/dl) | MEAN | |
| PRIMARY | Change in Interleukin 6 at Base to 24 Hours | Baseline - 24 hours | Micrograms per deciliter (ug/dl) | MEAN | |
| PRIMARY | Change in Interleukin 6 Baseline to 1 Week | Baseline - 1 week | Micrograms per deciliter (ug/dl) | MEAN | |
| PRIMARY | Change in Interleukin 6 24 Hours - 1 Week | 24 hours - 1 week | Micrograms per deciliter (ug/dl) | MEAN | |
| PRIMARY | Change in Interleukin 8 at Base to 24 Hours | Baseline - 24 hours | Micrograms per deciliter (ug/dl) | MEAN | |
| PRIMARY | Change in Interleukin 8 at Base to 1 Week | Baseline - 1 week | Micrograms per deciliter (ug/dl) | MEAN | |
| PRIMARY | Change in Interleukin 8 24 Hours to 1 Week | 24 hours - 1 week | Micrograms per deciliter (ug/dl) | MEAN | |
| PRIMARY | Change in Tumor Necrosis Factor Alpha at Base to 24 Hours | Baseline- 24hrs | Micrograms per deciliter (ug/dl) | MEAN | |
| PRIMARY | Change in Tumor Necrosis Factor Alpha at Base to 1 Week | Baseline - 1 week | Micrograms per deciliter (ug/dl) | MEAN | |
| PRIMARY | Change in Tumor Necrosis Factor Alpha 24 Hours to 1 Week | 24hrs - 1 week | Micrograms per deciliter (ug/dl) | MEAN | |
| SECONDARY | Gingival Index Level (Derived From an Average Over the 4 Implant Sites) at Baseline | Baseline | participants | NUMBER | |
| SECONDARY | Gingival Index Level (Derived From an Average Over the 4 Implant Sites) at 24 Hours | 24 hours | participants | NUMBER | |
| SECONDARY | Gingival Index Level (Derived From an Average Over the 4 Implant Sites) at 1 Week | 1 week | participants | NUMBER | |
| SECONDARY | Probing Depth Level (Averaged Over 6 Sites) at Baseline | Baseline | participants | NUMBER | |
| SECONDARY | Probing Depth Level (Averaged Over 6 Sites) at 24 Hours | 24 hours | participants | NUMBER | |
| SECONDARY | Probing Depth Level (Averaged Over 6 Sites) at 1 Week | 1 week | participants | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03400475/outcomes